FDA Panel to Vote on Flibanserin

posted on Jun 17 by in the Uncategorized category WASHINGTON (MedPage Today) -- The investigational drug that has been dubbed the "female Viagra" will come under scrutiny tomorrow by an FDA advisory panel.

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes